- Home
- CNTX vs APYX Comparison
CNTX vs APYX Comparison
Compare CNTX & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- APYX
- Stock Information
- Founded
- CNTX 2015
- APYX 1982
- Country
- CNTX United States
- APYX United States
- Employees
- CNTX N/A
- APYX N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- APYX Medical/Dental Instruments
- Sector
- CNTX Health Care
- APYX Health Care
- Exchange
- CNTX Nasdaq
- APYX Nasdaq
- Market Cap
- CNTX 78.0M
- APYX 85.0M
- IPO Year
- CNTX 2021
- APYX 1987
- Fundamental
- Price
- CNTX $0.79
- APYX $2.16
- Analyst Decision
- CNTX Strong Buy
- APYX Hold
- Analyst Count
- CNTX 5
- APYX 2
- Target Price
- CNTX $5.25
- APYX N/A
- AVG Volume (30 Days)
- CNTX 145.6K
- APYX 106.5K
- Earning Date
- CNTX 08-06-2025
- APYX 08-07-2025
- Dividend Yield
- CNTX N/A
- APYX N/A
- EPS Growth
- CNTX N/A
- APYX N/A
- EPS
- CNTX N/A
- APYX N/A
- Revenue
- CNTX N/A
- APYX $46,512,000.00
- Revenue This Year
- CNTX N/A
- APYX $2.25
- Revenue Next Year
- CNTX N/A
- APYX $6.76
- P/E Ratio
- CNTX N/A
- APYX N/A
- Revenue Growth
- CNTX N/A
- APYX N/A
- 52 Week Low
- CNTX $0.49
- APYX $0.76
- 52 Week High
- CNTX $2.70
- APYX $2.73
- Technical
- Relative Strength Index (RSI)
- CNTX 58.08
- APYX 51.76
- Support Level
- CNTX $0.68
- APYX $2.06
- Resistance Level
- CNTX $0.73
- APYX $2.70
- Average True Range (ATR)
- CNTX 0.05
- APYX 0.24
- MACD
- CNTX -0.00
- APYX 0.01
- Stochastic Oscillator
- CNTX 55.65
- APYX 66.28
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.